scholarly journals An Atypical Presentation of A Case of Endometriosis

2011 ◽  
Vol 19 (1) ◽  
pp. 27-30
Author(s):  
N Yusuf ◽  
MA Haque ◽  
MH Rahman ◽  
MA Ali
Keyword(s):  
Low Dose ◽  
Oral Contraceptive Pill ◽  
Clinical History ◽  
Presumptive Diagnosis ◽  
Pulmonary Infarction ◽  
Pulmonary Endometriosis ◽  
Dose Oral ◽  
Ovarian Pathology ◽  
Dose Oral Contraceptive

Bloody pleural effusion may be a clinical complication of many diseases like malignancy, trauma, pulmonary infarction, ovarian pathology, certain infections etc. Rarely pulmonary, endometriosis can present with haemothorax & pose a diagnostic problem to clinicians. Histopathological confirmation is difficult, since bleeding site is not easy to locate. However, a presumptive diagnosis of pulmonary endometriosis can be made with a typical clinical history. We report a case of pleural endometriosis in a 28 years infertile lady presented with catamenial haemothorax occurring in the first 3 days of menstruation over a 3 months period associated with right shoulder pain & progressive shortness of breath for last 6 years. She was treated with continuous low dose oral contraceptive pill & there was no evidence of recurrent haemothorax during 9 months of follow up period.   doi: 10.3329/taj.v19i1.3165 TAJ 2006; 19(1): 27-30

scholarly journals Duration of Oral Contraceptives Use and Risk of Development of Dyslipidemia among Women in Dhaka City

2017 ◽  
Vol 14 (2) ◽  
pp. 40-43
Author(s):  
Abida Sultana ◽  
Kashefa Khatun ◽  
Al Mamun Mahbub Alam
Keyword(s):  
Oral Contraceptive ◽  
Low Dose ◽  
Contraceptive Use ◽  
Oral Contraceptive Pill ◽  
Serum Triglyceride ◽  
Control Group ◽  
Case Group ◽  
Oral Contraceptive Use ◽  
Dose Oral ◽  
Dose Oral Contraceptive

AbstractBackground: Duration of oral contraceptive use is an important issue for the development of dyslipidemia among women.Objective: The purpose of the present study was to see the duration of use of OCP and the development of dyslipidemia among the women.Methodology: This case control study was carried out in the Department of Obstetrics & Gynaecology and Family Planning Department in collaboration with the Biochemistry Department at Sir Salimullah Medical College & Mitford Hospital, Dhaka from June 2009 to May 2010 for a period of one (1) year. Women using low-dose OC pill for more than one year were considered as cases group while women not using low-dose oral contraceptive pill were taken as control group of the study. Lipid profiles were performed in the laboratory in the fasting state from blood.Result: A total of 80 subjects were recruited for this study of which 40 women in case group and the rest 40 women were in control group. Duration of contraceptive use and serum lipids profiles were recorded. Level of serum total cholesterol, serum triglyceride, and serum LDL were significantly higher among the contraceptive users of > 5 years duration than those among 5 or < 5 years duration (p < 0.001). However, serum HDL level was low among both users and non-users (p=0.556). The risk of developing dyslipidaemia in women using low-dose oral contraceptive was more than 3-fold higher than that in non-users.Conclusion: In conclusion the greater the duration of oral contraceptive use the higher is the chance of dyslipidaemia.Journal of Science Foundation 2016;14(2):40-43

Erythema multiforme due to progesterone in a low-dose oral contraceptive pill

2005 ◽  
Vol 152 (2) ◽  
pp. 370-371 ◽  
Author(s):  
R. Suzuki ◽  
Y. Matsumura ◽  
N. Kambe ◽  
H. Fujii ◽  
T. Tachibana ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Erythema Multiforme ◽  
Low Dose ◽  
Oral Contraceptive Pill ◽  
Contraceptive Pill ◽  
Dose Oral ◽  
Dose Oral Contraceptive

scholarly journals Ultra-low-dose oral contraceptive pill: a new approach to a conventional requirement

2017 ◽  
Vol 6 (2) ◽  
pp. 364
Author(s):  
Meenakshi Ahuja ◽  
Pramod Pujari
Keyword(s):  
Side Effects ◽  
Low Dose ◽  
Oral Contraceptive Pill ◽  
New Approach ◽  
Breakthrough Bleeding ◽  
Free Interval ◽  
Dose Oral ◽  
Hormonal Fluctuations ◽  
Reversible Method ◽  
Dose Oral Contraceptive

Combined oral contraceptives (COCs) offer a convenient, safe, effective, and reversible method of contraception. However, their use is limited by side effects. Several strategies have been suggested to make COC use more acceptable among women. Reduction in the dose of estrogen is a commonly accepted approach to reduce the side effects of COC. Use of newer generation of progestins, such as gestodene, reduces the androgenic side effects generally associated with progestogens. Furthermore, reduction in hormone-free interval, as a 24/4 regimen, can reduce the risk of escape ovulation (hence preventing contraceptive failure) and breakthrough bleeding. It also reduces hormonal fluctuations, thereby reducing the withdrawal symptoms. A COC with gestodene 60 µg and ethinylestradiol (EE) 15 µg offers the lowest hormonal dose in 24/4 treatment regimen. This regimen has been shown to offer good contraceptive efficacy and cycle control. With the progress of treatment cycles, the incidence of breakthrough bleeding reduces. Gestodene/EE low dose 24/4 regimen was associated with lower incidence of estrogen-related adverse events, such as headache, breast tenderness, and nausea. Furthermore, COCs containing low dose of estrogen have not been associated with any adverse effect on haemostasis in healthy women. Ultra-low-dose COCs can be considered in women who are at risk of developing estrogen-related side effects.

Sign in / Sign up

Export Citation Format

Share Document